Similar articles

• Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.

  Feltgen N, Junker B, Agostini H, Hansen LL. Feltgen N, et al. Ophthalmology. 2007 Apr;114(4):716-23. doi: 10.1016/j.ophtha.2006.06.064. Epub 2006 Nov 30. Ophthalmology. 2007. PMID: 17141322 Clinical Trial.
• Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.

  Hattenbach LO, Friedrich Arndt C, Lerche R, Scharrer I, Baatz H, Margaron F, Richard G, Behrens-Baumann W, Ohrloff C. Hattenbach LO, et al. Retina. 2009 Jul-Aug;29(7):932-40. doi: 10.1097/IAE.0b013e3181a3b870. Retina. 2009. PMID: 19584651 Clinical Trial.
• Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.

  van Overdam KA, Missotten T, Spielberg LH. van Overdam KA, et al. Acta Ophthalmol. 2015 Dec;93(8):739-44. doi: 10.1111/aos.12830. Epub 2015 Aug 27. Acta Ophthalmol. 2015. PMID: 26310993
• Surgical treatment of central retinal vein occlusion.

  Berker N, Batman C. Berker N, et al. Acta Ophthalmol. 2008 May;86(3):245-52. doi: 10.1111/j.1755-3768.2007.01144.x. Acta Ophthalmol. 2008. PMID: 18494725 Review.
• Surgical treatments of central retinal vein occlusion.

  Parodi MB, Lanzetta P, Guarnaccia G, Friberg T. Parodi MB, et al. Semin Ophthalmol. 2003 Sep;18(3):142-6. doi: 10.1076/soph.18.3.142.29803. Semin Ophthalmol. 2003. PMID: 15513475 Review.